ViroXis Corporation   Report issue

For profit Phase 2
Founded: San Antonio TX United States (2006)
Status: Acquired by TFS Trial Form Support (2015)

Organization Overview

First Clinical Trial
2012
NCT01286441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (5)

Key: ViroXis Corporation (2) Acquired (3)

east indian sandalwood oil (1 trial)

eiso (2 trials)

san007 (2 trials)

san021 (2 trials)

vir007 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Condylomata Acuminata (Phase 2)

Molluscum Contagiosum (Phase 2)

Warts (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 5